Lewis Rhodes Laboratories is categorized under Commercial Medical Research in Maynard, MA and active since 2008.
Lewis Rhodes Laboratories was established in 2008, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5417112 by the NAICS.
If you are seeking more information, feel free to contact Lewis Rhodes, Owner at the company’s single location by writing to 2 Clock Tower Place # 360, Maynard, Massachusetts MA 01754 or by phoning (978) 897-0901. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Lewis Rhodes Laboratories |
| Contact Person: | Lewis Rhodes, Owner |
| Address: | 2 Clock Tower Place # 360, Maynard, Massachusetts 01754 |
| Phone Number: | (978) 897-0901 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5417112 |
| Share This Business: |
Lewis Rhodes Laboratories was started in 2008 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5417112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Lewis Rhodes, Owner for inquiries that concern Lewis Rhodes Laboratories by calling the company number (978) 897-0901, as your correspondence is most welcome. Additionally, the physical location of the single location of Lewis Rhodes Laboratories can be found at the coordinates 42.431674,-71.455629 as well as the street address 2 Clock Tower Place # 360 in Maynard, Massachusetts 01754.
For its online presence, you may visit Lewis Rhodes Laboratories’s website at and engage with its social media outlets through on Twitter and on Facebook.